These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 32071060)

  • 21. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis.
    López-Causapé C; Oliver A
    Future Microbiol; 2017 Dec; 12():1445-1448. PubMed ID: 29068237
    [No Abstract]   [Full Text] [Related]  

  • 23. Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients.
    Zamudio R; Hijazi K; Joshi C; Aitken E; Oggioni MR; Gould IM
    Int J Antimicrob Agents; 2019 Jun; 53(6):774-780. PubMed ID: 30831233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant Pseudomonas aeruginosa strains harbouring R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India.
    Shahid M; Malik A; Sheeba
    FEMS Microbiol Lett; 2003 Nov; 228(2):181-6. PubMed ID: 14638422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome analysis of a transmissible lineage of pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators.
    Marvig RL; Johansen HK; Molin S; Jelsbak L
    PLoS Genet; 2013; 9(9):e1003741. PubMed ID: 24039595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
    Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
    Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
    Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Rosales-Reyes R; Esposito F; Fontana H; Lezana-Fernández JL; Lascurain R; De la Cruz MA; Fuga B; Lincopan N; Santos-Preciado JI
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115454. PubMed ID: 34271235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.
    Cabot G; Zamorano L; Moyà B; Juan C; Navas A; Blázquez J; Oliver A
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1767-78. PubMed ID: 26729493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusually High Prevalence of Cosecretion of Ambler Class A and B Carbapenemases and Nonenzymatic Mechanisms in Multidrug-Resistant Clinical Isolates of
    Yaghi J; Fattouh N; Akkawi C; El Chamy L; Maroun RG; Khalil G
    Microb Drug Resist; 2020 Feb; 26(2):150-159. PubMed ID: 31424353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence.
    Barceló IM; Torrens G; Escobar-Salom M; Jordana-Lluch E; Capó-Bauzá MM; Ramón-Pallín C; García-Cuaresma D; Fraile-Ribot PA; Mulet X; Oliver A; Juan C
    Microbiol Spectr; 2022 Feb; 10(1):e0201921. PubMed ID: 35171032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in Gene
    Bolard A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients.
    D'Argenio DA; Wu M; Hoffman LR; Kulasekara HD; Déziel E; Smith EE; Nguyen H; Ernst RK; Larson Freeman TJ; Spencer DH; Brittnacher M; Hayden HS; Selgrade S; Klausen M; Goodlett DR; Burns JL; Ramsey BW; Miller SI
    Mol Microbiol; 2007 Apr; 64(2):512-33. PubMed ID: 17493132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
    Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
    Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
    J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.
    Qin X; Zerr DM; McNutt MA; Berry JE; Burns JL; Kapur RP
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5971-81. PubMed ID: 22964251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.
    Salunkhe P; Smart CH; Morgan JA; Panagea S; Walshaw MJ; Hart CA; Geffers R; Tümmler B; Winstanley C
    J Bacteriol; 2005 Jul; 187(14):4908-20. PubMed ID: 15995206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
    Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
    mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.